4//SEC Filing
TURKEL CATHERINE C. 4
Accession 0001855763-24-000013
CIK 0001348362other
Filed
Aug 12, 8:00 PM ET
Accepted
Aug 13, 10:55 AM ET
Size
11.2 KB
Accession
0001855763-24-000013
Insider Transaction Report
Form 4
TURKEL CATHERINE C.
Director
Transactions
- Purchase
common shares
2024-08-12$3.13/sh+1,600$5,008→ 3,100 total
Holdings
- 1,500
common shares
- 5,000
Stock Options
Exercise: $1.96From: 2022-10-12Exp: 2027-10-12→ Common Shares (1,600 underlying) - 27,000
Stock Options
Exercise: $3.39From: 2024-07-26Exp: 2029-07-26→ Common Shares (12,000 underlying) - 3,400
Stock Options
Exercise: $3.04From: 2022-09-02Exp: 2027-09-02→ Common Shares (3,400 underlying) - 10,000
Stock Options
Exercise: $0.87From: 2023-07-25Exp: 2028-07-25→ Common Shares (5,000 underlying) - 15,000
Stock Options
Exercise: $2.36From: 2024-04-26Exp: 2029-04-26→ Common Shares (5,000 underlying)
Documents
Issuer
Lexaria Bioscience Corp.
CIK 0001348362
Entity typeother
Related Parties
1- filerCIK 0001705278
Filing Metadata
- Form type
- 4
- Filed
- Aug 12, 8:00 PM ET
- Accepted
- Aug 13, 10:55 AM ET
- Size
- 11.2 KB